Facebook Linkedin Twitter
Inside Precision Medicine New Method Shows Promise to Deliver Therapeutics Across the Blood-Brain Barrier

Gene therapy (Genetic engineering)

Astrocytes, which may help form the blood-brain barrier
News & Features

New Method Shows Promise to Deliver Therapeutics Across the Blood-Brain Barrier

0
Molecule of mRNA, illustration
Precision Medicine

Innovative Packaging of mRNA Therapeutics Improves Their Delivery and Speeds Development

Anita Chakraverty
0
Illustration of red blood cells moving through clogged artery to indicate cholesterol build up as a result of familial hypercholesterolemia and atherosclerosis, which can be caused by high levels of lipoprotein(a) or Lp(a).
News & Features

Lipoprotein(a) Lowering Draw Between Lilly and Silence

0
Man with Duchenne muscular dystrophy sitting in a motorized wheelchair using power controller with degenerated hands
News & Features

Sizing it Up: New Method Enables Large Gene Delivery to Treat Muscular Dystrophies

0
Degradation of a motor neuron presented as an illustration. Shows the kind of damage seen in ALS, which may be worsened by alpha-5 integrin
News & Features

Trace Neuroscience Launches with $101M and a Potential Genomic ALS Target

0
muscle fiber
News & Features

In Conversation with Frank Gleeson

Helen Albert
0
Image showing pathological phosphorylation (yellow) of Tau proteins (red-orange) leads to disintegration of microtubuli in the neuron axon an aggregation of the tau proteins. The transport of synaptic vesicles (orange-blue) is interrupted. This is just part of the disease pathology seen in a single cell map of the Alzheimer's disease brain.
News & Features

New Therapy Shows Promise in Targeting Tau Tangles in Alzheimer’s Disease

0
Cancer Gene
News & Features

New DNA-Targeting Screening Technique for Cancer Therapies

0
Genetic engineering concept. DNA. Gene therapy. Medical technology
News & Features

New Gene Therapy for Muscular Dystrophy May Facilitate Development of Others

0
Image of a heart with a DNA double helix in front of it to indicate cardiovascular disease and the impact of transthyretin amyloid cardiomyopathy (ATTR-CM) which can be treated with vutrisiran.
News & Features

Alnylam’s Vutrisiran Gets Good Results for Cardiac Amyloidosis

0
123...14Page 1 of 14

Related Content

Copyright © 2024 Genetic Engineering & Biotechnology News. All Rights Reserved.
Inside Precision Medicine